PRP for Tennis Elbow

Could PRP Help Your Elbow?

Tennis elbow — lateral epicondylitis — is one of the most studied conditions in PRP medicine, and for good reason: it is common, it is often resistant to standard treatment, and it has a clear biological rationale for why PRP might help. The evidence tells a consistent story, with one important nuance around timing.

For patients in Walnut Creek and throughout the East Bay who have not found lasting relief with rest, bracing, physical therapy, or corticosteroid injections, PRP is a well-supported option — particularly for those who want more durable relief than repeated cortisone shots can provide.

What Is Tennis Elbow?

Despite its name, tennis elbow affects far more non-athletes than athletes. It is caused by overuse and repetitive strain of the forearm extensor tendons where they attach to the lateral epicondyle — the bony prominence on the outer elbow. The underlying pathology is tendinosis, not tendinitis — meaning it is a degenerative process driven by microscopic tendon breakdown rather than acute inflammation.

This distinction matters clinically: because tennis elbow is fundamentally degenerative rather than inflammatory, anti-inflammatory treatments like corticosteroids address symptoms rather than the underlying pathology — which is why their relief tends to be temporary. PRP, by contrast, targets the degenerative process directly.

Common presentations include:

  • Lateral elbow pain worsened by gripping, lifting, or extending the wrist
  • Pain with everyday activities such as opening jars, shaking hands, or using a computer mouse
  • Symptoms persisting for months despite rest and conservative treatment

How PRP Works for Tennis Elbow

A small blood sample is drawn and processed to concentrate the platelets. The resulting platelet-rich plasma is injected directly into the affected tendon under ultrasound guidance for precise delivery. Platelets release growth factors — including PDGF, TGF-β, IGF-1, and VEGF — that signal tendon cells to begin the repair process, stimulate new collagen formation, and modulate the degenerative environment within the tendon.

Unlike corticosteroids, which suppress the inflammatory response temporarily, PRP aims to restart a healing process that the degenerating tendon has failed to complete on its own. This explains why PRP’s benefits tend to emerge gradually over weeks to months rather than days.

What the Evidence Shows — The Case For PRP

Tennis elbow has one of the most consistent and voluminous PRP evidence bases of any musculoskeletal condition:

  • A 2025 meta-analysis of 26 RCTs including 1,877 patients found long-term results (beyond 6 months) significantly favored PRP over corticosteroids for both pain and functional outcomes — this is the largest meta-analysis conducted to date on this topic
  • A systematic review of 11 RCTs with 730 patients found PRP provides significantly better long-term improvement in pain scores, DASH functional scores, and Mayo Elbow Performance Score compared to corticosteroids
  • Multiple RCTs demonstrate PRP superiority over corticosteroids from approximately 1 month through up to 2 years — representing sustained, durable relief that corticosteroids have not matched in head-to-head comparisons
  • PRP has been shown to significantly improve tendon healing on MRI over a 2-year follow-up period and on ultrasound imaging at 9 months — one of the few regenerative treatments with objective structural improvement data
  • PRP has been found superior to corticosteroids, saline, dry needling in long-term outcomes — and comparable to surgery — making it the strongest non-surgical option supported by current evidence
  • Both leukocyte-rich (LR-PRP) and leukocyte-poor (LP-PRP) preparations achieve clinically meaningful improvements in validated outcome scores for tennis elbow

Important nuance — platelet concentration matters: A 2025 study from Hospital for Special Surgery found that platelet concentration alone explained 58.5% of the variability in PRP outcomes across studies. High-dose PRP with supraphysiological platelet concentration produced significantly better outcomes, while low-dose PRP showed no meaningful benefit over alternative treatments. This is one of the most clinically important findings in the recent PRP literature — it means not all PRP is equivalent, and preparation quality is critical.

What the Evidence Shows — The Case for Caution

  • Short-term, corticosteroids win: Across virtually all studies, corticosteroid injections provide faster and better short-term pain relief in the first 4–8 weeks. Patients who need rapid relief to return to work or activity may do better with corticosteroids as a bridge, with PRP as a longer-term strategy
  • High placebo response: A well-designed four-arm RCT comparing PRP, corticosteroids, hyaluronic acid, and saline placebo found beneficial effects across all four groups — suggesting proper injection technique and the therapeutic encounter itself may contribute meaningfully to outcomes, independent of what is injected. Tennis elbow has high natural resolution rates, making it one of the most susceptible conditions to placebo effects in clinical trials
  • PRP vs. placebo not always superior: A meta-analysis of placebo-controlled trials found PRP was not consistently superior to saline injection — both groups improved. This challenges the assumption that PRP’s benefits over corticosteroids reflect true biological superiority rather than simply more durable placebo response
  • Variable outcomes across studies: Results remain sensitive to PRP preparation quality, platelet concentration, injection technique, and tendon acuity. Studies using low-dose PRP have shown no benefit over alternatives
  • Most benefit in chronic cases: PRP appears most effective for chronic, refractory tennis elbow that has failed conservative care — evidence is less robust for acute or mild presentations where natural resolution is likely

What This Means for Patient Selection

PRP for tennis elbow is most appropriate when:

  • Symptoms have persisted for at least 3–6 months despite physical therapy, bracing, and activity modification
  • Prior corticosteroid injections provided only temporary relief or are no longer appropriate due to concerns about repeated steroid use
  • The patient prioritizes long-term resolution over short-term rapid relief
  • Imaging confirms tendinosis or partial tendon degeneration consistent with symptoms

PRP is less likely to be the right first choice when:

  • Symptoms are acute or recent — rest, physical therapy, and bracing should be tried first
  • Short-term rapid relief is the primary need — corticosteroids act faster
  • Mild symptoms with high likelihood of natural resolution

Before Your Procedure

Avoid NSAIDs (such as ibuprofen, Mobic, naproxen, or Celebrex) for at least one week before and one week after your PRP injection. NSAIDs directly counteract the inflammatory signaling that drives PRP’s healing mechanism.

What to Expect

The procedure is performed in-office under ultrasound guidance. A small blood sample is drawn, processed on-site, and injected into the lateral epicondyle tendon attachment under direct ultrasound visualization. The procedure typically takes under an hour.

Expect mild to moderate soreness at the injection site for several days following the procedure — this is a normal part of the biological response. Most patients notice meaningful improvement in pain and grip strength within 4–8 weeks, with continued gains possible over several months. The long-term data for PRP in tennis elbow is among the most encouraging of any tendon condition.

From a Research & Clinical Perspective

Tennis elbow has one of the strongest and most consistent long-term evidence bases for PRP of any musculoskeletal condition. A 2025 meta-analysis of 26 RCTs and 1,877 patients clearly demonstrates PRP superiority over corticosteroids at 6 months and beyond. However, corticosteroids win in the short term, placebo response is high in this condition, and platelet concentration appears to be a critical — and often underreported — variable in determining outcomes. Dr. Murakami will review the evidence alongside her clinical experience to discuss whether PRP is the right option for your elbow and what preparation protocol is most appropriate for your presentation.

Sources & Further Reading

The following peer-reviewed studies informed the content on this page. Links open in a new tab.

Supporting Evidence

Negative and Limiting Evidence

This page was last reviewed March 2026.

Elbow PRP Consultation in Walnut Creek with Dr. Murakami